The northern German dairy Uelzena eG will hold a 50 % stake in Biohealth International GmbH, Münchberg (BHI) and will integrate its nutrineo- health food solutions business division into the joint company. The contract was signed on 13 May 2020. The parties agreed not to disclose the purchase price. With this move, partners Stefan Gebhardt, MIDAS Private Equity, and Uelzena eG wish to jointly serve the market for nutritional supplements, sports nutrition and dietary foods.
Excellent market position for professional health food solutions
Biohealth International has a joint turnover of about EUR 45 million and employ more than 250 staff at three sites in Germany and Austria. The new company offers a broad range of product solutions: from powdered blends in various small package sizes to capsules, tablets, ampoules and bars to liquid supplements and beverages – all standard product categories are available to customers. As a contract manufacturer for brand products and retail, the joint company is characterised by its speed and professionalism.
New company combines a broad product portfolio and tremendous capacity for innovation
Mr Uwe Radke, Managing Director of Uelzena eG, is appointed along with Mr Stefan Gebhardt to the executive management of BHI. The partners want to develop the company into one of the leading providers in the health food market and plan to further expand production capacity at the site in Münchberg.
“With the joint venture, nutrineo and Biohealth International share the clear common objective of further developing their position as one of the leading providers in the private label health market,” says Jörn Dwehus, Managing Director of Uelzena eG. “The strengths in production expertise and quality of Uelzena/Biohealth International perfectly complement the flexibility and the broad product portfolio of BHI. We look forward to offering our customers an expanded range of services.”